Uncategorized
Glaukos submits IND to study iDose travoprost implant
Glaukos submitted an investigational new drug application to the FDA for a travoprost intraocular implant with the iDose delivery system, according to a press release.The system is designed to reduce IOP in patients with glaucoma.